88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Metabolon Expands Microbiome Panel to Strengthen Industry Leadership in Functional Microbiome Research Enhanced panel screens for more than 800 microbiome-associated metabolites, giving researchers a broader view of microbial activity linked to human health, nutrition, disease, and treatment response ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Bambusa Therapeutics Appoints Howard Liang, Ph.D. to its Board of Directors and Establishes Scientific Advisory Board Dr. Liang brings deep biopharma finance, strategy, and capital markets expertise to support the company's next phase of growth ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ractigen Therapeutics Announces Landmark Publication in Nature Medicine Highlighting Unprecedented Preclinical Efficacy and Positive First-in-Human Clinical Data for RAG-17 in SOD1-ALS — Peer-reviewed publication details RAG-17's robust translation from "bench to bedside," validating the proprietary SCAD™ delivery platform for CNS-targeted RNAi therapies — ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , July 15, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ascletis Selects for Clinical Development a Fixed-Dose Combination of First-in-Class Oral Small Molecule GIPR Agonist, ASC48, and Oral Small Molecule GLP-1R Agonist, ASC30 - ASC48 is a potentially first-in-class oral small molecule GIPR agonist. ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Asthma CHENGDU, China , July 15, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) and Harbour BioMed (HKEX: 02142) today ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
World-renowned bioelectronics pioneer Prof. John Rogers to present second PAIR--Cambridge NeuroWorks online neuroscience seminar HONG KONG , July 15, 2026 /PRNewswire/ -- The PolyU Academy for Interdisciplinary Research (PAIR) of The Hong Kong Polytechnic University has partnered with Cambridge NeuroWorks, UK—an alliance ... 2026-07-15T Biotechnology Computer/Electronics Education Higher Education
GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million TAIPEI and SAN DIEGO , July 15, 2026 /PRNewswire/ -- GEM Global Yield LLC SCS ("GEM") has executed a Share Purchase Agreement (the "SPA") with the existing shareholders of Taiwan-listed ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development Combines Insilico's Pharma.AI platform with Bora's global development, manufacturing, quality, and commercialization capabilities to explore a next-generation drug innovation model ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis HANGZHOU, China and SHANGHAI and BOSTON , July 15, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved